Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 530
interventional 402
Observational 118
Registry 10

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 145
Drug|placebo 78
Device 55
Procedure 52
Device|Drug 11
Device|Procedure 8
Other 8
Diagnostic Test 6
Drug|Other 6
Device|Other 5
Biological 4
Dietary Supplement 3
Behavioral 2
Behavioral|Other 2
Device|Drug|Procedure 2
Dietary Supplement|Drug|placebo 2
Dietary Supplement|placebo 2
Behavioral|Drug 1
Biological|Drug 1
Biological|placebo 1
Combination Product 1
Device|Drug|Other 1
Dietary Supplement|Drug 1
Dietary Supplement|Other 1
Drug|Other|Radiation 1
Drug|Procedure 1
Genetic 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 106
NA 35
Korea, Republic of 33
China 19
France 17
Egypt 14
Taiwan 13
Italy 12
Canada 10
Japan 10
Germany 6
Turkey 6
United Kingdom 6
United States|Canada 6
Netherlands 5
Spain 5
Australia 4
Brazil 4
Hong Kong 4
India 4
Mexico 4
Norway 4
Australia|New Zealand 3
Finland 3
Russian Federation 3
Denmark 2
Iran, Islamic Republic of 2
Israel 2
Switzerland 2
United States|Puerto Rico 2
Australia|Austria|Belgium|France|Germany|Greece|Italy|Mexico|Netherlands|Poland 1
Australia|Austria|Canada|Czech Republic|France|Germany|Italy|Korea, Republic of|Slovakia|Taiwan|United Kingdom 1
Australia|Belgium|Canada|Chile|Colombia|Denmark|Finland|Greece|Italy|Latvia|Lithuania|Poland|Slovakia|Spain|United Kingdom 1
Australia|France|Germany|Greece|Hungary|Netherlands|Spain 1
Australia|Georgia|Taiwan 1
Austria 1
Austria|Belarus|Belgium|Czechia|France|Germany|Italy|Netherlands|Poland|Slovakia|United Kingdom 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hungary|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Spain|Sweden|United Kingdom 1
Austria|Switzerland 1
Bangladesh 1
Belgium 1
Belgium|Czech Republic|Finland|France|Germany|Israel|Italy|Netherlands 1
Belgium|Italy|Spain|Switzerland|United Kingdom 1
Bulgaria|New Zealand 1
China|Japan|Korea, Republic of|Taiwan 1
Colombia|Ecuador|Guatemala|Mexico 1
Czech Republic|Netherlands|Slovakia 1
Czechia|Dominican Republic|Sweden 1
Denmark|Germany|United Kingdom 1
Dominican Republic 1
Dominican Republic|Panama 1
France|Brazil|Czechia|Israel|Spain 1
France|Germany|Greece|Italy|Netherlands|Romania|Spain|United Kingdom 1
France|Germany|Italy|Russian Federation|Spain 1
France|Italy|Portugal|Spain 1
Germany|Austria|Belarus|Belgium|Czech Republic|France|Hungary|Italy|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom 1
Hungary 1
Japan|Korea, Republic of 1
Japan|Taiwan 1
Lebanon 1
New Zealand|Singapore 1
Portugal 1
Russian Federation|Ukraine 1
Singapore 1
Spain|Czech Republic|France|Germany|Italy 1
Spain|United States|Canada|Czechia|France|Germany|Italy|Poland|United Kingdom 1
Sweden 1
Thailand 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|Iceland|Israel|Italy|Puerto Rico|Korea, Republic of|Lithuania|Mexico|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|Taiwan|Thailand|Tunisia|Turkey|United Kingdom| 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Greece|Italy|Mexico|Poland|Russian Federation|Turkey 1
United States|Argentina|Germany|Italy|Mexico 1
United States|Australia|Bulgaria|Canada|Denmark|Finland|Greece|Hungary|Israel|Netherlands|Norway|Poland|Portugal|Romania|South Africa|Spain|Sweden 1
United States|Australia|Canada 1
United States|Australia|Canada|New Zealand|Russian Federation|Ukraine 1
United States|Australia|New Zealand|United Kingdom 1
United States|Austria|Italy 1
United States|Belgium|Canada|Czech Republic|Italy|Poland 1
United States|Canada|Czechia|France|Germany|Korea, Republic of|Philippines|Poland 1
United States|Canada|France|Germany|Greece|Italy|Mexico|Portugal|Russian Federation 1
United States|France|Germany|Italy|United Kingdom 1
United States|France|Italy|United Kingdom 1
United States|Greece|Portugal 1
United States|India 1
United States|Italy 1
United States|Spain|Belgium|Canada|Hungary|Lithuania|Poland 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 259
2 17
3 11
4 9
5 7
6 11
7 6
8 7
9 7
10 1
11 5
12 1
13 3
14 3
15 5
16 3
17 6
19 2
21 1
26 1
27 3
28 1
30 1
31 1
32 1
33 1
34 1
35 1
40 1
41 2
42 1
43 1
44 1
45 1
46 2
47 1
48 1
52 1
54 1
58 1
65 1
67 1
70 1
76 1
79 2
80 1
95 1
98 1
118 1
119 1
123 1
504 1

Phase

Phase Study_Count
N/A 135
Phase 2 66
Phase 3 63
Phase 4 63
Phase 1 49
Phase 2/Phase 3 11
Phase 1/Phase 2 10
Early Phase 1 5

Number of Arms

Number_of_Arms Count_of_Studies
1 118
2 183
3 48
4 16
5 2
6 2
8 2
9 2
NA 29

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1 5.0000 8.00000 12.000 5.0000 13.0000 21.0000 2.0000
1st Qu. 18 33.0000 27.00000 18.750 26.0000 100.0000 160.0000 63.0000
Median 36 80.0000 34.00000 31.500 97.0000 224.0000 451.0000 120.0000
Mean 43 311.8209 37.02041 62.625 154.8923 447.8182 618.5556 272.1746
3rd Qu. 40 160.0000 46.00000 83.250 200.0000 745.0000 636.5000 329.0000
Max. 120 11925.0000 86.00000 180.000 919.0000 1400.0000 4844.0000 1993.0000

Trial Group Type

group_type Group_Count
Experimental 399
Active Comparator 209
Placebo Comparator 86
Other 35
NA 29
No Intervention 14
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 223
Single Group Assignment 128
Crossover Assignment 46
Sequential Assignment 3
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 320
Prevention 31
Diagnostic 14
Basic Science 11
Other 9
Supportive Care 7
NA 5
Screening 4
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 36
NA 26
France 8
Korea, Republic of 7
Italy 5
Canada 4
Singapore 3
Switzerland 3
United Kingdom 3
Austria 2
China 2
Denmark 2
Germany 2
Colombia 1
Croatia 1
Finland 1
Greece|Italy|Portugal|Spain|Turkey 1
Kazakhstan 1
Kenya 1
Norway 1
Philippines 1
Poland 1
Spain 1
Sweden 1
Turkey 1
United States|Argentina 1
United States|France|Germany|Italy|United Kingdom 1
United States|Japan|Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 103
2 4
3 1
4 1
5 2
7 1
8 1
11 1
18 1
27 1
73 1
161 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 54.000
Median 177.000
Mean 2344.534
3rd Qu 833.500
Max 54459.000

Observation Model

observational_model Study_Count
Cohort 72
NA 18
Case-Only 13
Other 6
Case Control 5
Case-Control 4

Time Perspective

time_perspective Study_Count
Prospective 67
Retrospective 26
Cross-Sectional 11
NA 10
Other 3
Cross-Sectional, Prospective 1

Registries

Studies by Country

Country Study_Count
Philippines 2
China 1
Egypt 1
France 1
Italy 1
Korea, Republic of 1
Switzerland 1
United States 1
United States|France|Germany|Italy|Norway|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 8
4 1
10 1

Enrollment Metrics

Measure Registries
Min 200
1st Qu 300
Median 400
Mean 440
3rd Qu 500
Max 925

Registry Model

observational_model Study_Count
Cohort 5
Case-Only 2
Ecologic or Community 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 6
Cross-Sectional 3
Other 1

Follow-up

target_duration Study_Count
1 Year 2
12 Months 2
2 Years 2
5 Years 2
3 Months 1
4 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03297281 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) https://ClinicalTrials.gov/show/NCT03297281 Recruiting Clinique Pasteur 2021-11-30
NCT03385161 Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03385161 Completed Cairo University 2015-06-30
NCT01297205 Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01297205 Completed Medipost Co Ltd. 2011-09-30
NCT04124393 Multicenter Evaluation of Right Colon Polyp Miss Rates Using Water Exchange Versus CO2 Insufflation https://ClinicalTrials.gov/show/NCT04124393 Recruiting Evergreen General Hospital, Taiwan 2021-05-31
NCT03305861 Green LEP vs ThuLEP in Management of Marked Enlarged Prostate https://ClinicalTrials.gov/show/NCT03305861 Recruiting Mansoura University 2019-12-01
NCT03300557 Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer https://ClinicalTrials.gov/show/NCT03300557 Recruiting National Cancer Institute (NCI) 2021-12-01
NCT01974401 Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia https://ClinicalTrials.gov/show/NCT01974401 Completed Mashhad University of Medical Sciences 2011-03-31
NCT03279744 A Study to Evaluate the Efficacy and Safety of Radionâ„¢-Pdt in Patients With Oral Precancerous Lesion https://ClinicalTrials.gov/show/NCT03279744 Completed Pharma Power Biotec Co., Ltd. 2019-09-04
NCT03271177 Ultrasound Comparison of Radial Artery Hyperplasia After Use of a 7F Sheathless Guide vs. 6F Sheath/Guide Combination https://ClinicalTrials.gov/show/NCT03271177 Completed Tallahassee Research Institute, Inc. 2017-03-13
NCT03268993 Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03268993 Recruiting University of Pittsburgh 2022-12-31
NCT03264482 High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH https://ClinicalTrials.gov/show/NCT03264482 Active, not recruiting Mansoura University 2018-12-02
NCT03257462 Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03257462 Completed Spruce Biosciences 2019-04-15
NCT03246880 Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients https://ClinicalTrials.gov/show/NCT03246880 Completed Chong Kun Dang Pharmaceutical 2016-04-30
NCT03241888 Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia https://ClinicalTrials.gov/show/NCT03241888 Completed Fudan University 2020-06-18
NCT03240939 Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil https://ClinicalTrials.gov/show/NCT03240939 Completed Yuyu Pharma, Inc. 2017-07-07
NCT03239652 Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03239652 Recruiting National Cheng-Kung University Hospital 2020-06-30
NCT03230721 ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH https://ClinicalTrials.gov/show/NCT03230721 Completed I.M. Sechenov First Moscow State Medical University 2017-04-22
NCT03209843 Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO) https://ClinicalTrials.gov/show/NCT03209843 Active, not recruiting Poitiers University Hospital 2021-03-14
NCT03207074 Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? https://ClinicalTrials.gov/show/NCT03207074 Completed Imperial College London 2019-06-20
NCT03207061 Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? https://ClinicalTrials.gov/show/NCT03207061 Recruiting Imperial College London 2020-12-01
NCT03189966 Truncal Blocks for Pediatric With Developmental Dysplasia of the Hip Undergoing Open Reduction https://ClinicalTrials.gov/show/NCT03189966 Completed Second Affiliated Hospital of Wenzhou Medical University 2018-07-01
NCT03182959 Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT03182959 Active, not recruiting University of Arizona 2021-12-31
NCT03167294 AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03167294 Completed PROCEPT BioRobotics 2016-06-30
NCT03157726 Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate https://ClinicalTrials.gov/show/NCT03157726 Recruiting Zhujiang Hospital 2020-06-06
NCT03144596 The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil https://ClinicalTrials.gov/show/NCT03144596 Completed Kocatepe University 2016-02-03
NCT03125889 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II https://ClinicalTrials.gov/show/NCT03125889 Completed PROCEPT BioRobotics 2017-04-18
NCT03125863 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03125863 Completed PROCEPT BioRobotics 2016-09-03
NCT03123250 Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II https://ClinicalTrials.gov/show/NCT03123250 Active, not recruiting PROCEPT BioRobotics 2018-03-27
NCT03109925 Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement https://ClinicalTrials.gov/show/NCT03109925 Recruiting University Hospital Southampton NHS Foundation Trust 2019-10-31
NCT03097679 Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions https://ClinicalTrials.gov/show/NCT03097679 Active, not recruiting Medical University of Vienna 2019-07-31
NCT01781117 Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01781117 Completed Samsung Medical Center 2016-11-30
NCT03062280 A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH https://ClinicalTrials.gov/show/NCT03062280 Active, not recruiting Diurnal Limited 2020-02-29
NCT03055624 Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03055624 Completed University of California, San Diego 2019-02-18
NCT03052049 Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres https://ClinicalTrials.gov/show/NCT03052049 Active, not recruiting Northwestern University 2020-03-01
NCT03051893 A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations https://ClinicalTrials.gov/show/NCT03051893 Completed Diurnal Limited 2012-04-30
NCT04146103 A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH https://ClinicalTrials.gov/show/NCT04146103 Completed Saint-Joseph University 2019-01-31
NCT03032848 Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients https://ClinicalTrials.gov/show/NCT03032848 Completed Universidade Federal do Paraná 2016-12-20
NCT03027557 Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. https://ClinicalTrials.gov/show/NCT03027557 Completed Aalborg University Hospital 2019-04-01
NCT03005795 Music and Colposcopy in Women With Cervical Dysplasia. https://ClinicalTrials.gov/show/NCT03005795 Completed Zydolab - Institute of Cytology and Immune Cytochemistry 2018-05-02
NCT02977832 Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02977832 Completed IRCCS Policlinico S. Matteo 2016-07-31
NCT02972268 Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH https://ClinicalTrials.gov/show/NCT02972268 Completed Jeil Pharmaceutical Co., Ltd. 2017-11-02
NCT02962674 To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH. https://ClinicalTrials.gov/show/NCT02962674 Active, not recruiting ProstaCare Singapore Pte. Ltd. 2019-09-30
NCT02943070 Rezum I Pilot Study for BPH https://ClinicalTrials.gov/show/NCT02943070 Completed Boston Scientific Corporation 2013-02-28
NCT02940392 Rezum FIM Optimization https://ClinicalTrials.gov/show/NCT02940392 Completed Boston Scientific Corporation 2012-12-31
NCT02930889 Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02930889 Recruiting University of Minnesota 2020-10-31
NCT02928978 Ruxolitinib for Premalignant Breast Disease https://ClinicalTrials.gov/show/NCT02928978 Recruiting Baylor Breast Care Center 2022-01-31
NCT02872818 Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT02872818 Completed Kayseri Education and Research Hospital 2015-03-31
NCT02869971 Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02869971 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT02855892 A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH https://ClinicalTrials.gov/show/NCT02855892 Completed GemVax & Kael 2016-10-31
NCT02846467 Information Improvement for Surgical Patients Through Portable Video Media https://ClinicalTrials.gov/show/NCT02846467 Completed Hospital Universitario Puerto Real 2015-10-31
NCT02839122 A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02839122 Completed Yuyu Pharma, Inc. 2016-09-30
NCT02822924 Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02822924 Recruiting Chinese University of Hong Kong 2020-04-30
NCT02786290 The Zenflow Spring System Feasibility and Safety Study https://ClinicalTrials.gov/show/NCT02786290 Active, not recruiting Zenflow, Inc. 2019-12-31
NCT02778776 Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02778776 Completed Centro Universitario de Ciencias de la Salud, Mexico 2015-06-30
NCT02778243 Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level https://ClinicalTrials.gov/show/NCT02778243 Completed Hopital Foch 2016-11-12
NCT02757963 Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years https://ClinicalTrials.gov/show/NCT02757963 Completed GlaxoSmithKline 2017-02-27
NCT02757768 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02757768 Completed Astellas Pharma Inc 2018-08-14
NCT02737865 Superb Microvascular Imaging in Focal Nodular Hyperplasia https://ClinicalTrials.gov/show/NCT02737865 Completed Samsung Medical Center 2019-04-25
NCT02716818 Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT02716818 Completed Diurnal Limited 2018-07-28
NCT02715401 PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02715401 Completed Hanmi Pharmaceutical Company Limited 2015-11-30
NCT02715024 Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms https://ClinicalTrials.gov/show/NCT02715024 Completed Astellas Pharma Inc 2011-04-30
NCT02712411 Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02712411 Completed Hanmi Pharmaceutical Company Limited 2015-08-31
NCT02697175 Video Colposcopy in Women With Dysplasia https://ClinicalTrials.gov/show/NCT02697175 Completed Zydolab - Institute of Cytology and Immune Cytochemistry 2017-03-31
NCT02681471 Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT02681471 Completed Istanbul University 2015-04-30
NCT02645890 Study to Compare the Safety and Pharmacokinetics of CKD-397 https://ClinicalTrials.gov/show/NCT02645890 Completed Chong Kun Dang Pharmaceutical 2015-12-31
NCT02637960 Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02637960 Completed Vantia Ltd 2017-07-31
NCT02634489 EC905 Pharmacokinetic Profile Study https://ClinicalTrials.gov/show/NCT02634489 Completed Astellas Pharma Inc 2009-07-31
NCT02625545 Study of Median Lobe Prostatic UroLift Procedure https://ClinicalTrials.gov/show/NCT02625545 Completed NeoTract, Inc. 2017-05-30
NCT02620696 Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin https://ClinicalTrials.gov/show/NCT02620696 Completed Trio Medicines Ltd. 2010-09-30
NCT02605759 Coldplay Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell Dysplasia https://ClinicalTrials.gov/show/NCT02605759 Completed C2 Therapeutics, Inc. 2018-01-27
NCT02592473 Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02592473 Recruiting University of Virginia 2021-11-30
NCT02999373 Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates https://ClinicalTrials.gov/show/NCT02999373 Completed Guangdong Women and Children Hospital 2020-01-01
NCT02574910 Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 https://ClinicalTrials.gov/show/NCT02574910 Active, not recruiting University of Texas Southwestern Medical Center 2021-01-23
NCT00001521 Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00001521 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02524236 Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. https://ClinicalTrials.gov/show/NCT02524236 Completed Beni-Suef University 2016-11-30
NCT02509104 Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02509104 Completed GlaxoSmithKline 2015-10-10
NCT02506465 Pivotal Study to Assess the Safety and Effectiveness of the iTind Device https://ClinicalTrials.gov/show/NCT02506465 Completed Medi-Tate Ltd. 2018-10-31
NCT02505919 Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) https://ClinicalTrials.gov/show/NCT02505919 Completed PROCEPT BioRobotics 2017-07-14
NCT02494349 The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. https://ClinicalTrials.gov/show/NCT02494349 Completed Jeil Pharmaceutical Co., Ltd. 2015-11-30
NCT02443961 Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies https://ClinicalTrials.gov/show/NCT02443961 Recruiting Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2020-04-30
NCT02423759 A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy https://ClinicalTrials.gov/show/NCT02423759 Completed Mansoura University 2017-01-16
NCT02417844 Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. https://ClinicalTrials.gov/show/NCT02417844 Completed Boehringer Ingelheim 2015-05-31
NCT02417831 Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. https://ClinicalTrials.gov/show/NCT02417831 Completed Boehringer Ingelheim 2015-05-31
NCT02397083 Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer https://ClinicalTrials.gov/show/NCT02397083 Recruiting M.D. Anderson Cancer Center 2026-09-30
NCT02381366 Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study https://ClinicalTrials.gov/show/NCT02381366 Completed Medipost America Inc. 2016-09-30
NCT02366975 TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST https://ClinicalTrials.gov/show/NCT02366975 Completed University of Florence 2017-01-31
NCT02342730 Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia https://ClinicalTrials.gov/show/NCT02342730 Completed Case Comprehensive Cancer Center 2015-05-18
NCT02332538 HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH https://ClinicalTrials.gov/show/NCT02332538 Completed Mansoura University 2016-07-31
NCT02330471 Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial https://ClinicalTrials.gov/show/NCT02330471 Completed Ruhr University of Bochum 2015-03-31
NCT02326454 A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02326454 Completed Light Sciences Oncology 2017-03-29
NCT02313233 Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02313233 Completed Golden Biotechnology Corporation 2015-05-31
NCT02303769 Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS https://ClinicalTrials.gov/show/NCT02303769 Completed GL Pharm Tech Corporation 2015-05-31
NCT02283684 GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT https://ClinicalTrials.gov/show/NCT02283684 Completed Mansoura University 2015-11-30
NCT02252367 Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02252367 Active, not recruiting University of Florence 2019-01-31
NCT02245490 Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms https://ClinicalTrials.gov/show/NCT02245490 Completed Boehringer Ingelheim 2004-04-30
NCT02244294 FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02244294 Completed Boehringer Ingelheim 2005-06-30
NCT02244255 FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244255 Completed Boehringer Ingelheim 2000-06-30
NCT02244242 Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244242 Completed Boehringer Ingelheim 1999-08-31
NCT02244229 Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients https://ClinicalTrials.gov/show/NCT02244229 Completed Boehringer Ingelheim 2000-11-30
NCT02239484 Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin https://ClinicalTrials.gov/show/NCT02239484 Completed Hanmi Pharmaceutical Company Limited 2014-09-30
NCT02184585 Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States https://ClinicalTrials.gov/show/NCT02184585 Completed GlaxoSmithKline 2015-02-23
NCT02180997 Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin https://ClinicalTrials.gov/show/NCT02180997 Completed Jeil Pharmaceutical Co., Ltd. 2015-03-31
NCT02180789 A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation https://ClinicalTrials.gov/show/NCT02180789 Completed Astellas Pharma Inc 2015-01-31
NCT02167919 Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02167919 Completed University of North Carolina, Chapel Hill 2017-05-01
NCT02167009 Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams https://ClinicalTrials.gov/show/NCT02167009 Recruiting Tampa General Hospital 2020-05-31
NCT02145208 Study to Assess the Efficacy of Medi-Tate iTind Device https://ClinicalTrials.gov/show/NCT02145208 Active, not recruiting Medi-Tate Ltd. 2017-12-31
NCT02026908 Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02026908 Active, not recruiting Northwestern University 2020-06-01
NCT02121613 PERmixon® in LUTS Evaluation Study (PERLES) https://ClinicalTrials.gov/show/NCT02121613 Completed Pierre Fabre Medicament 2016-06-30
NCT02106182 Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02106182 Completed JW Pharmaceutical 2016-03-02
NCT03966950 Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia https://ClinicalTrials.gov/show/NCT03966950 Recruiting University of Sao Paulo 2019-11-26
NCT02074644 Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02074644 Completed Hospital St. Louis, Lisbon, Portugal 2019-03-03
NCT02072499 KTP Green Light Prostatectomy Compared With Open Prostatectomy https://ClinicalTrials.gov/show/NCT02072499 Completed University of Helsinki 2017-06-30
NCT02058368 Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02058368 Completed GlaxoSmithKline 2017-03-03
NCT01294592 Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement https://ClinicalTrials.gov/show/NCT01294592 Completed GlaxoSmithKline 2013-10-17
NCT01294150 The Safety and Effectiveness of UroLift: LIFT Pivotal Study https://ClinicalTrials.gov/show/NCT01294150 Completed NeoTract, Inc. 2013-02-28
NCT01275521 A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy https://ClinicalTrials.gov/show/NCT01275521 Completed University Hospital, Bordeaux 2015-04-28
NCT02054013 Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02054013 Active, not recruiting Cantonal Hospital of St. Gallen 2017-09-19
NCT02051036 Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study https://ClinicalTrials.gov/show/NCT02051036 Completed Korean Medicine Hospital of Pusan National University 2015-12-31
NCT02041767 Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration https://ClinicalTrials.gov/show/NCT02041767 Completed Assistance Publique - Hôpitaux de Paris 2015-01-31
NCT02038868 A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT02038868 Completed Astellas Pharma Inc 2014-04-04
NCT02011308 KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate) https://ClinicalTrials.gov/show/NCT02011308 Completed University of Helsinki 2015-10-31
NCT01975363 Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer https://ClinicalTrials.gov/show/NCT01975363 Completed Ohio State University Comprehensive Cancer Center 2016-09-19
NCT01968317 Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma https://ClinicalTrials.gov/show/NCT01968317 Completed Fudan University 2017-10-31
NCT01963312 Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. https://ClinicalTrials.gov/show/NCT01963312 Completed Fundacion Miguel Servet 2018-04-30
NCT01957189 This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples https://ClinicalTrials.gov/show/NCT01957189 Completed GlaxoSmithKline 2014-01-22
NCT01952912 Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates https://ClinicalTrials.gov/show/NCT01952912 Completed Fuzhou General Hospital 2007-06-30
NCT01942551 Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride https://ClinicalTrials.gov/show/NCT01942551 Completed Dongkook Pharmaceutical Co., Ltd. 2013-12-31
NCT01939184 Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01939184 Completed Warner Chilcott 2014-03-31
NCT01937871 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) https://ClinicalTrials.gov/show/NCT01937871 Completed Eli Lilly and Company 2015-12-31
NCT01935752 Pathophysiological Mechanisms of Fibromuscular Dysplasia https://ClinicalTrials.gov/show/NCT01935752 Completed Assistance Publique - Hôpitaux de Paris 2014-10-31
NCT01924988 Prostate Embolization for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01924988 Completed Georgetown University 2017-04-30
NCT01922375 Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01922375 Completed Dong-A ST Co., Ltd. 2012-09-30
NCT01912339 Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT01912339 Completed Boston Scientific Corporation 2015-03-31
NCT01905046 Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer https://ClinicalTrials.gov/show/NCT01905046 Recruiting Alliance for Clinical Trials in Oncology 2022-06-30
NCT01892332 The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients https://ClinicalTrials.gov/show/NCT01892332 Completed Yonsei University 2014-01-31
NCT01876706 UroLift System TOlerability and ReCovery When Administering Local Anesthesia https://ClinicalTrials.gov/show/NCT01876706 Completed NeoTract, Inc. 2014-10-31
NCT01874184 Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer https://ClinicalTrials.gov/show/NCT01874184 Completed University of Washington 2015-04-30
NCT03645525 Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD) https://ClinicalTrials.gov/show/NCT03645525 Recruiting Children’s Hospital of Fudan University 2020-10-30
NCT01859312 Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT01859312 Completed National Institutes of Health Clinical Center (CC) 2016-12-02
NCT01846793 Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) https://ClinicalTrials.gov/show/NCT01846793 Completed Nymox Corporation 2014-10-31
NCT03612570 Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia https://ClinicalTrials.gov/show/NCT03612570 Completed Pulse Biosciences, Inc. 2018-11-28
NCT01835860 Prostatic Artery Embolization for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01835860 Completed Saskatchewan Health Authority - Regina Area 2015-12-31
NCT01818934 Ultrasound Screening for Developmental Dysplasia of the Hip in Newborns https://ClinicalTrials.gov/show/NCT01818934 Completed University of Bergen 1990-06-30
NCT03350529 MRI Guided Transurethral HIFU for Various Prostate Diseases https://ClinicalTrials.gov/show/NCT03350529 Active, not recruiting Turku University Hospital 2020-12-31
NCT01791842 TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE https://ClinicalTrials.gov/show/NCT01791842 Completed Hospices Civils de Lyon 2015-05-31
NCT01777269 Prospective Sexual Function Study for BPH Subjects https://ClinicalTrials.gov/show/NCT01777269 Completed GlaxoSmithKline 2016-04-05
NCT01775462 Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) https://ClinicalTrials.gov/show/NCT01775462 Completed Edimer Pharmaceuticals 2015-12-31
NCT01764542 Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors https://ClinicalTrials.gov/show/NCT01764542 Completed Sahlgrenska University Hospital, Sweden 2015-01-31
NCT01757769 Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01757769 Completed Recordati Industria Chimica e Farmaceutica S.p.A. 2013-03-31
NCT01747577 Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) https://ClinicalTrials.gov/show/NCT01747577 Completed Astellas Pharma Inc 2013-10-31
NCT01735617 Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH https://ClinicalTrials.gov/show/NCT01735617 Completed Diurnal Limited 2013-12-31
NCT01716104 Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression https://ClinicalTrials.gov/show/NCT01716104 Completed Materia Medica Holding 2016-11-30
NCT01686126 Improving the Treatment for Women With Early Stage Cancer of the Uterus https://ClinicalTrials.gov/show/NCT01686126 Active, not recruiting Queensland Centre for Gynaecological Cancer 2020-08-31
NCT01685762 Metformin for the Treatment of Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT01685762 Completed UNC Lineberger Comprehensive Cancer Center 2015-12-01
NCT01678313 Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels https://ClinicalTrials.gov/show/NCT01678313 Completed Buddhist Tzu Chi General Hospital 2013-08-31
NCT01675895 Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration https://ClinicalTrials.gov/show/NCT01675895 Completed Diskapi Teaching and Research Hospital 2011-07-31
NCT01665586 Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study https://ClinicalTrials.gov/show/NCT01665586 Completed Yonsei University 2013-09-30
NCT01657851 Bioequivalence - Duodart Against Avodart & Omnic https://ClinicalTrials.gov/show/NCT01657851 Completed GlaxoSmithKline 2012-12-05
NCT01627522 Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate https://ClinicalTrials.gov/show/NCT01627522 Completed Shiraz University of Medical Sciences 2013-03-31
NCT01604811 Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) https://ClinicalTrials.gov/show/NCT01604811 Completed Pierre Fabre Medicament 2013-10-31
NCT01589263 Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH) https://ClinicalTrials.gov/show/NCT01589263 Completed VA Office of Research and Development 2019-09-30
NCT01577693 Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01577693 Completed GlaxoSmithKline 2011-08-31
NCT01566292 Intraprostatic Botulinum Toxin Type “A” Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy https://ClinicalTrials.gov/show/NCT01566292 Completed Catholic University of the Sacred Heart 2010-09-30
NCT01500057 Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01500057 Completed Brooklyn Urology Research Group 2016-10-10
NCT01499602 Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women https://ClinicalTrials.gov/show/NCT01499602 Completed Mansoura University 2011-11-30
NCT01495026 A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia https://ClinicalTrials.gov/show/NCT01495026 Completed GlaxoSmithKline 2012-04-03
NCT01494337 Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) https://ClinicalTrials.gov/show/NCT01494337 Completed Royal Victoria Hospital, Canada 2014-03-31
NCT01471678 Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. https://ClinicalTrials.gov/show/NCT01471678 Completed GlaxoSmithKline 2011-09-07
NCT01460342 Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01460342 Completed Eli Lilly and Company 2012-10-31
NCT01454778 Effects of Paclitaxel on Intimal Hyperplasia https://ClinicalTrials.gov/show/NCT01454778 Completed Sanford Health 2014-10-31
NCT01454349 Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01454349 Completed Sophiris Bio Corp 2013-03-31
NCT01441063 Tocilizumab for KSHV-Associated Multicentric Castleman Disease https://ClinicalTrials.gov/show/NCT01441063 Active, not recruiting National Institutes of Health Clinical Center (CC) 2018-06-06
NCT01438775 Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01438775 Completed Nymox Corporation 2013-01-31
NCT01436877 Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT01436877 Completed Medi-Tate Ltd. 2016-09-30
NCT01387893 A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01387893 Completed Kaiser Permanente 2009-03-31
NCT01372644 Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial https://ClinicalTrials.gov/show/NCT01372644 Completed NYU Langone Health 2010-12-31
NCT01360541 Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia https://ClinicalTrials.gov/show/NCT01360541 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2019-05-31
NCT01330303 SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin https://ClinicalTrials.gov/show/NCT01330303 Completed GlaxoSmithKline 2009-12-22
NCT03669549 Nevanimibe HCl for the Treatment of Classic CAH https://ClinicalTrials.gov/show/NCT03669549 Recruiting Millendo Therapeutics, Inc. 2020-12-31
NCT03595735 The Zenflow Spring System Safety, Performance and Effectiveness Study https://ClinicalTrials.gov/show/NCT03595735 Recruiting Zenflow, Inc. 2020-12-30
NCT04391114 Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04391114 Recruiting Thunder Bay Regional Research Institute 2021-10-15
NCT04386941 Greenlight Vaporization vs Xpeeda Vaporesection https://ClinicalTrials.gov/show/NCT04386941 Recruiting Thunder Bay Regional Research Institute 2022-07-10
NCT04385667 LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT04385667 Recruiting Zagazig University 2021-05-30
NCT04353050 Atypical MOLes and Melanoma Early Detection Study (MoleMed) https://ClinicalTrials.gov/show/NCT04353050 Recruiting Russian Academy of Medical Sciences 2022-01-01
NCT04331301 Needlescopic Enucleation Versus Vapoenucleation of BPH https://ClinicalTrials.gov/show/NCT04331301 Recruiting Benha University 2020-08-01
NCT04308070 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III https://ClinicalTrials.gov/show/NCT04308070 Completed PROCEPT BioRobotics 2018-03-22
NCT04299425 Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy https://ClinicalTrials.gov/show/NCT04299425 Recruiting Vanderbilt-Ingram Cancer Center 2021-03-31
NCT04275076 HoLEP Vs BPEP for Large Prostatic Adenoma https://ClinicalTrials.gov/show/NCT04275076 Completed Ain Shams University 2020-02-01
NCT04271020 Urodynamic Feasibility Study Utilizing the UroLift® System https://ClinicalTrials.gov/show/NCT04271020 Completed NeoTract, Inc. 2019-04-22
NCT04263987 A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial https://ClinicalTrials.gov/show/NCT04263987 Recruiting Vanderbilt University Medical Center 2020-05-31
NCT04253418 Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study https://ClinicalTrials.gov/show/NCT04253418 Active, not recruiting Pulse Biosciences, Inc. 2020-02-29
NCT04229706 A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation) https://ClinicalTrials.gov/show/NCT04229706 Recruiting Tasly Pharmaceuticals, Inc. 2021-07-31
NCT04212403 Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) https://ClinicalTrials.gov/show/NCT04212403 Completed Jessa Hospital 2019-12-23
NCT04209088 Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation https://ClinicalTrials.gov/show/NCT04209088 Recruiting University Hospital, Limoges 2022-03-06
NCT04198103 Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04198103 Active, not recruiting University of Rome Tor Vergata 2019-11-01
NCT04170257 Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions https://ClinicalTrials.gov/show/NCT04170257 Recruiting Beijing Cancer Hospital 2021-12-31
NCT04131907 A Clinical Study to Evaluate the Safety and Efficacy of the Optilumeâ„¢ BPH Catheter System in Men With Symptomatic BPH https://ClinicalTrials.gov/show/NCT04131907 Recruiting Urotronic Inc. 2021-06-30
NCT04108871 Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men https://ClinicalTrials.gov/show/NCT04108871 Recruiting The University of Hong Kong 2021-06-01
NCT04107896 Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04107896 Completed Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 2018-08-31
NCT04103450 Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04103450 Enrolling by invitation Urovant Sciences GmbH 2021-07-31
NCT04084938 Artery Embolization vs Operation of Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT04084938 Recruiting Oslo University Hospital 2022-12-31
NCT04062136 Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT04062136 Recruiting Vinmec Research Institute of Stem Cell and Gene Technology 2020-11-30
NCT04054713 Acetic Acid for the Detection of Esophageal Neoplasms https://ClinicalTrials.gov/show/NCT04054713 Recruiting Coordinación de Investigación en Salud, Mexico 2019-12-03
NCT04045145 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT04045145 Recruiting Neurocrine Biosciences 2020-06-30
NCT04044573 Focal Laser Ablation for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04044573 Recruiting University of Rome Tor Vergata 2023-04-05
NCT03992937 Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT03992937 Recruiting Kocaeli University 2020-12-31
NCT03191734 French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue https://ClinicalTrials.gov/show/NCT03191734 Completed PROCEPT BioRobotics 2018-07-02
NCT03972371 The ProVerum First in Man PROVE Study https://ClinicalTrials.gov/show/NCT03972371 Active, not recruiting ProVerum Medical 2021-11-30
NCT03936244 Bipolar Plasmakinetic TURP Versus Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03936244 Active, not recruiting Hospital Universitario de Fuenlabrada 2017-12-12
NCT03912558 Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients. https://ClinicalTrials.gov/show/NCT03912558 Recruiting Butterfly Medical Ltd. 2019-10-31
NCT03902080 Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03902080 Recruiting Urovant Sciences GmbH 2020-11-30
NCT03897504 Surgical Evaluation of Using the Prepuce in Feminizing Genitoplasty https://ClinicalTrials.gov/show/NCT03897504 Recruiting Kasr El Aini Hospital 2020-01-01
NCT03887871 Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers After Meal https://ClinicalTrials.gov/show/NCT03887871 Completed Chong Kun Dang Pharmaceutical 2019-03-22
NCT03873506 Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03873506 Recruiting Children’s Hospital of Chongqing Medical University 2020-07-01
NCT03856242 Benign Prostatic Hyperplasia and Ischemic Heart DIsease https://ClinicalTrials.gov/show/NCT03856242 Completed I.M. Sechenov First Moscow State Medical University 2017-09-01
NCT03846700 Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques https://ClinicalTrials.gov/show/NCT03846700 Recruiting University of Bari 2019-10-01
NCT03831321 The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy https://ClinicalTrials.gov/show/NCT03831321 Recruiting Istanbul Medeniyet University 2019-04-22
NCT03829904 The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03829904 Completed Taipei Veterans General Hospital, Taiwan 2020-01-02
NCT03814824 Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS) https://ClinicalTrials.gov/show/NCT03814824 Recruiting Northwell Health 2020-06-30
NCT03814629 Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer https://ClinicalTrials.gov/show/NCT03814629 Active, not recruiting ShuGuang Hospital 2019-09-30
NCT03760835 Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment https://ClinicalTrials.gov/show/NCT03760835 Recruiting Federico II University 2021-12-31
NCT03718234 Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03718234 Recruiting University of Minnesota 2022-07-01
NCT02346500 Ultrasound-Guided Photoselective Vaporization of the Prostate https://ClinicalTrials.gov/show/NCT02346500 Completed Johns Hopkins University 2016-11-26
NCT03687242 Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03687242 Completed Spruce Biosciences 2019-09-17
NCT03675139 MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia https://ClinicalTrials.gov/show/NCT03675139 Recruiting Fudan University 2022-02-25
NCT03669692 Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. https://ClinicalTrials.gov/show/NCT03669692 Recruiting Complexo Hospitalario Universitario de A Coruña 2022-12-10
NCT03653117 Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT03653117 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2019-07-31
NCT03649932 Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing https://ClinicalTrials.gov/show/NCT03649932 Recruiting The University of Texas Medical Branch, Galveston 2019-09-10
NCT03596437 Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome https://ClinicalTrials.gov/show/NCT03596437 Recruiting Assistance Publique - Hôpitaux de Paris 2019-03-31
NCT03577236 The Zenflow Spring System EU Safety and Performance Study https://ClinicalTrials.gov/show/NCT03577236 Recruiting Zenflow, Inc. 2021-12-31
NCT01218243 An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01218243 Completed Guang’anmen Hospital of China Academy of Chinese Medical Sciences 2012-03-31
NCT03558334 Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03558334 Recruiting Children’s Hospital of Chongqing Medical University 2021-12-31
NCT03554070 Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety https://ClinicalTrials.gov/show/NCT03554070 Active, not recruiting I.M. Sechenov First Moscow State Medical University 2020-03-01
NCT03538977 Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03538977 Recruiting Universidade Estadual de Londrina 2019-05-31
NCT03527589 Embosphere® PROstate Post Market Study https://ClinicalTrials.gov/show/NCT03527589 Active, not recruiting Merit Medical Systems, Inc. 2022-09-01
NCT03521063 Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. https://ClinicalTrials.gov/show/NCT03521063 Recruiting Hospital Central “Dr. Ignacio Morones Prieto” 2019-10-30
NCT03503721 Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate https://ClinicalTrials.gov/show/NCT03503721 Recruiting Salzburger Landeskliniken 2021-01-18
NCT03469310 Minimizing Narcotic Analgesics After Endocrine Surgery https://ClinicalTrials.gov/show/NCT03469310 Active, not recruiting Doctors Hospital at Renaissance 2019-12-21
NCT03463252 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC https://ClinicalTrials.gov/show/NCT03463252 Recruiting West China Second University Hospital 2019-12-30
NCT03423979 Optilumeâ„¢ BPH Prostatic Drug Coated Balloon Dilation Catheter https://ClinicalTrials.gov/show/NCT03423979 Active, not recruiting Urotronic Inc. 2019-06-04
NCT01259531 Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) https://ClinicalTrials.gov/show/NCT01259531 Completed JW Pharmaceutical 2011-09-30
NCT01254071 A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. https://ClinicalTrials.gov/show/NCT01254071 Completed GlaxoSmithKline 2010-12-21
NCT01301599 Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01301599 Completed Samsung Medical Center 2013-07-31
NCT01222650 A Comparative Study of KSO-0400 in BPH Patients With LUTS https://ClinicalTrials.gov/show/NCT01222650 Completed Kissei Pharmaceutical Co., Ltd. NA
NCT01262989 SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin https://ClinicalTrials.gov/show/NCT01262989 Completed GlaxoSmithKline 2010-01-26
NCT01183650 A Study of Tadalafil in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01183650 Completed Eli Lilly and Company 2011-04-30
NCT01152190 A Study in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01152190 Completed Eli Lilly and Company 2012-07-31
NCT01140178 A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx https://ClinicalTrials.gov/show/NCT01140178 Completed Roswell Park Cancer Institute 2013-01-29
NCT01139762 A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms https://ClinicalTrials.gov/show/NCT01139762 Completed Eli Lilly and Company 2012-02-29
NCT01118260 Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection https://ClinicalTrials.gov/show/NCT01118260 Completed Asker & Baerum Hospital 2009-05-31
NCT01114035 Characterization Phenotypic and Genetic Study of the Intestinal Epithelial Dysplasia or Tufting Enteropathy (TE) https://ClinicalTrials.gov/show/NCT01114035 Completed Assistance Publique - Hôpitaux de Paris 2013-04-30
NCT01107392 Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01107392 Completed Allergan 2012-03-16
NCT01074892 A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT01074892 Completed University Hospital of North Norway 2013-12-31
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use https://ClinicalTrials.gov/show/NCT01050465 Completed University of Missouri-Columbia 2010-10-31
NCT01049165 Single Ascending Dose (BMS-813160) Study https://ClinicalTrials.gov/show/NCT01049165 Completed Bristol-Myers Squibb 2010-11-30
NCT01043588 TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management https://ClinicalTrials.gov/show/NCT01043588 Completed Assistance Publique - Hôpitaux de Paris 2009-12-31
NCT01039285 Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01039285 Active, not recruiting Maternite Regionale Universitaire 2012-12-31
NCT01035190 Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01035190 Completed University Children’s Hospital Tuebingen 2013-10-31
NCT01021332 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01021332 Completed Astellas Pharma Inc 2011-12-14
NCT01018511 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01018511 Completed Astellas Pharma Inc 2011-03-31
NCT01002664 Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002664 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002417 MCS in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002417 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT01002274 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002274 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002222 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) https://ClinicalTrials.gov/show/NCT01002222 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT00970632 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00970632 Completed Eli Lilly and Company 2011-01-31
NCT00969072 Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00969072 Completed GlaxoSmithKline 2005-02-28
NCT00968656 Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 https://ClinicalTrials.gov/show/NCT00968656 Completed Washington University School of Medicine 2011-11-30
NCT00962390 Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00962390 Completed Ausio Pharmaceuticals, LLC 2016-01-31
NCT00947882 A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00947882 Completed Ferring Pharmaceuticals 2011-03-31
NCT00945490 Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 https://ClinicalTrials.gov/show/NCT00945490 Completed Nymox Corporation 2014-05-31
NCT00941343 Benign Prostatic Hyperplasia in Taiwan https://ClinicalTrials.gov/show/NCT00941343 Completed Sanofi 2008-09-30
NCT00939120 Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT00939120 Completed Siami, Paul F., M.D. 2014-09-30
NCT00931632 Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants https://ClinicalTrials.gov/show/NCT00931632 Completed Mallinckrodt 2013-05-31
NCT00926276 The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT00926276 Completed The University of Texas Health Science Center, Houston 2013-05-31
NCT00922506 Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00922506 Completed Samsung Medical Center 2014-05-31
NCT00918983 Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00918983 Completed Nymox Corporation 2013-11-30
NCT00908427 Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00908427 Completed Samsung Medical Center 2006-05-31
NCT00894517 A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00894517 Completed Allergan 2012-06-30
NCT00890851 Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration https://ClinicalTrials.gov/show/NCT00890851 Completed Assistance Publique - Hôpitaux de Paris 2008-12-31
NCT00889707 Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00889707 Completed Sophiris Bio Corp 2009-12-31
NCT00880672 Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate https://ClinicalTrials.gov/show/NCT00880672 Completed Seoul National University Hospital 2008-12-31
NCT00877669 Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH https://ClinicalTrials.gov/show/NCT00877669 Completed Samsung Medical Center 2016-07-31
NCT00861588 Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00861588 Completed Chinese University of Hong Kong 2007-09-30
NCT00855582 A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00855582 Completed Eli Lilly and Company 2010-07-31
NCT00848081 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers https://ClinicalTrials.gov/show/NCT00848081 Completed Eli Lilly and Company 2009-12-31
NCT00843258 Treatment for Mild Hip Dysplasia in Newborns https://ClinicalTrials.gov/show/NCT00843258 Completed University of Bergen 2003-04-30
NCT02509975 Safety and Efficacy of OCL 503 in Prostate Artery Embolization https://ClinicalTrials.gov/show/NCT02509975 Completed IMBiotechnologies Ltd. 2018-05-31
NCT02390882 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH https://ClinicalTrials.gov/show/NCT02390882 Completed Hanmi Pharmaceutical Company Limited 2015-05-31
NCT00918034 Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00918034 Completed Light Sciences Oncology 2011-02-28
NCT00861757 Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00861757 Completed Eli Lilly and Company 2010-06-30
NCT00836823 Evaluation of Symptom-specific Goal Achievement https://ClinicalTrials.gov/show/NCT00836823 Completed Samsung Medical Center 2008-08-31
NCT00827814 Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT00827814 Completed Samsung Medical Center 2009-04-30
NCT00827242 Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily https://ClinicalTrials.gov/show/NCT00827242 Completed Eli Lilly and Company 2009-11-30
NCT03600766 Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study https://ClinicalTrials.gov/show/NCT03600766 Active, not recruiting Mansoura University 2020-01-01
NCT03207126 Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? https://ClinicalTrials.gov/show/NCT03207126 Recruiting Imperial College London 2020-12-20
NCT03194737 Prostatic Urethral Lift in Subject With Acute Urinary Retention https://ClinicalTrials.gov/show/NCT03194737 Active, not recruiting NeoTract, Inc. 2018-12-31
NCT03061435 Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. https://ClinicalTrials.gov/show/NCT03061435 Recruiting Sunnybrook Health Sciences Centre 2020-12-31
NCT03001791 Comparison of ER:YAG Laser, CO2 Laser and Scalpel Excision of Fibrous Hyperplasia on the Buccal Mucosa https://ClinicalTrials.gov/show/NCT03001791 Completed University of Bern 2017-07-04
NCT02737241 HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH https://ClinicalTrials.gov/show/NCT02737241 Completed Mansoura University 2017-03-01
NCT00814736 A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 https://ClinicalTrials.gov/show/NCT00814736 Completed Pfizer 2008-09-30
NCT01966614 Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH https://ClinicalTrials.gov/show/NCT01966614 Completed Sophiris Bio Corp 2015-12-31
NCT01533038 BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01533038 Completed NeoTract, Inc. 2015-10-31
NCT04006574 Developmental Hip Dysplasia and Physical Therapy https://ClinicalTrials.gov/show/NCT04006574 Completed Hacettepe University 2019-09-01
NCT03887858 Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03887858 Completed Chong Kun Dang Pharmaceutical 2019-03-22
NCT03525886 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03525886 Recruiting Neurocrine Biosciences 2019-12-31
NCT03099421 Prostatic Artery Embolization for Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT03099421 Completed Rigshospitalet, Denmark 2018-12-14
NCT03019614 An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone https://ClinicalTrials.gov/show/NCT03019614 Completed Diurnal Limited 2010-04-30
NCT02804178 A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT02804178 Completed Millendo Therapeutics, Inc. 2017-08-17
NCT02667938 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules https://ClinicalTrials.gov/show/NCT02667938 Completed Hanmi Pharmaceutical Company Limited 2016-01-31
NCT02581137 Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion https://ClinicalTrials.gov/show/NCT02581137 Active, not recruiting National Cancer Institute (NCI) 2017-10-12
NCT02578953 Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects https://ClinicalTrials.gov/show/NCT02578953 Completed GlaxoSmithKline 2015-12-15
NCT02447367 Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02447367 Completed Jeil Pharmaceutical Co., Ltd. 2015-09-30
NCT02035787 Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients https://ClinicalTrials.gov/show/NCT02035787 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-12-31
NCT02431754 A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). https://ClinicalTrials.gov/show/NCT02431754 Completed Eli Lilly and Company 2016-02-29
NCT01829893 PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination https://ClinicalTrials.gov/show/NCT01829893 Completed Korea University Anam Hospital 2012-02-29
NCT03938194 Waterjet Prostate Ablation https://ClinicalTrials.gov/show/NCT03938194 Recruiting Chinese University of Hong Kong 2020-09-30
NCT03845933 Right Colon Polyp Miss Rates of Water Exchange and Carbon Dioxide Insufflation Colonoscopy https://ClinicalTrials.gov/show/NCT03845933 Completed Evergreen General Hospital, Taiwan 2019-10-31
NCT03758222 Safety and Feasibility of the Mercury Expander System https://ClinicalTrials.gov/show/NCT03758222 Recruiting MedeonBio, Inc. 2020-12-31
NCT00793819 A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00793819 Completed Watson Pharmaceuticals 2009-10-31
NCT00788671 Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer https://ClinicalTrials.gov/show/NCT00788671 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT00783094 Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension https://ClinicalTrials.gov/show/NCT00783094 Completed Eli Lilly and Company 2009-06-30
NCT00771394 Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00771394 Completed Astellas Pharma Inc 2010-01-31
NCT00759135 Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00759135 Completed Nymox Corporation 2008-01-31
NCT00730418 Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00730418 Completed Samsung Medical Center 2010-03-31
NCT00709488 Phase 1 Study of the Litxâ„¢ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00709488 Completed Light Sciences Oncology 2011-04-30
NCT00701779 Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00701779 Completed Siami, Paul F., M.D. 2009-07-31
NCT00700505 A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy https://ClinicalTrials.gov/show/NCT00700505 Completed ThermaRx, Inc. 2009-10-31
NCT00680680 Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker https://ClinicalTrials.gov/show/NCT00680680 Completed Franklin D. Gaylis, MD Inc. 2008-02-29
NCT00675688 Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00675688 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2006-01-31
NCT00657839 Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00657839 Completed Bayer NA
NCT00648323 Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement https://ClinicalTrials.gov/show/NCT00648323 Completed Pfizer NA
NCT00645034 A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin https://ClinicalTrials.gov/show/NCT00645034 Completed Pfizer NA
NCT00637715 Once Daily Given Alfuzosin in the Treatment of BPH https://ClinicalTrials.gov/show/NCT00637715 Completed Sanofi NA
NCT00637481 A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer https://ClinicalTrials.gov/show/NCT00637481 Completed National Cancer Institute (NCI) 2012-10-31
NCT00623740 PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates https://ClinicalTrials.gov/show/NCT00623740 Completed Assistance Publique - Hôpitaux de Paris 2016-01-31
NCT00620087 Molecular Breast Imaging in Women With Atypia and LCIS https://ClinicalTrials.gov/show/NCT00620087 Completed Mayo Clinic 2015-07-31
NCT00609596 A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. https://ClinicalTrials.gov/show/NCT00609596 Completed GlaxoSmithKline 2008-04-23
NCT00596011 Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00596011 Completed H. Lee Moffitt Cancer Center and Research Institute 2014-03-25
NCT00547625 Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems https://ClinicalTrials.gov/show/NCT00547625 Completed Eli Lilly and Company NA
NCT00540124 Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men https://ClinicalTrials.gov/show/NCT00540124 Completed Eli Lilly and Company 2008-06-30
NCT00537654 A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State https://ClinicalTrials.gov/show/NCT00537654 Completed GlaxoSmithKline 2008-02-22
NCT00529841 Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00529841 Completed Baylor College of Medicine 2008-09-30
NCT00527605 Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00527605 Completed GlaxoSmithKline 2009-03-31
NCT00527488 Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. https://ClinicalTrials.gov/show/NCT00527488 Completed Ferring Pharmaceuticals 2009-03-31
NCT00527371 PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate https://ClinicalTrials.gov/show/NCT00527371 Completed St. Joseph’s Healthcare Hamilton 2013-02-28
NCT00540891 The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score https://ClinicalTrials.gov/show/NCT00540891 Completed Sanofi NA
NCT00519818 Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00519818 Completed Diurnal Limited 2009-05-31
NCT00517179 Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS https://ClinicalTrials.gov/show/NCT00517179 Completed Hospital Authority, Hong Kong NA
NCT00510406 A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH https://ClinicalTrials.gov/show/NCT00510406 Completed Astellas Pharma Inc 2007-09-30
NCT00490087 Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women https://ClinicalTrials.gov/show/NCT00490087 Completed IRCCS Burlo Garofolo 2007-03-31
NCT00486785 SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin https://ClinicalTrials.gov/show/NCT00486785 Completed Sanofi 2007-10-31
NCT00483327 Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate https://ClinicalTrials.gov/show/NCT00483327 Completed NYU Langone Health 2013-10-31
NCT00465101 A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization https://ClinicalTrials.gov/show/NCT00465101 Completed American Medical Systems 2012-08-31
NCT00457457 Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. https://ClinicalTrials.gov/show/NCT00457457 Completed Pfizer 2008-04-30
NCT00453960 Genistein and Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT00453960 Completed University of Messina 2008-11-30
NCT00451191 Botulinum Toxin Injection for the Management of BPH https://ClinicalTrials.gov/show/NCT00451191 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-06-30
NCT00427882 Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study https://ClinicalTrials.gov/show/NCT00427882 Completed Handok Inc. NA
NCT00412321 A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Castleman’s Disease https://ClinicalTrials.gov/show/NCT00412321 Completed Centocor, Inc. 2011-04-30
NCT00409357 Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00409357 Completed Sanofi 2005-08-31
NCT00408954 Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT00408954 Completed Pfizer 2008-06-30
NCT00401661 Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin https://ClinicalTrials.gov/show/NCT00401661 Completed Sanofi 2007-12-31
NCT00399464 Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00399464 Completed Sanofi 2007-10-31
NCT00394758 A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia https://ClinicalTrials.gov/show/NCT00394758 Completed University Hospitals Cleveland Medical Center NA
NCT00386009 Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00386009 Completed Eli Lilly and Company 2008-05-31
NCT00384930 Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00384930 Completed Eli Lilly and Company 2007-10-31
NCT00379067 A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. https://ClinicalTrials.gov/show/NCT00379067 Completed Astellas Pharma Inc 2006-11-30
NCT00375765 Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer https://ClinicalTrials.gov/show/NCT00375765 Completed GlaxoSmithKline 2007-07-31
NCT00374114 A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia https://ClinicalTrials.gov/show/NCT00374114 Completed University of Tennessee NA
NCT00364585 A Prospective Evaluation of the GreenLight Model 120 Laser https://ClinicalTrials.gov/show/NCT00364585 Completed Weill Medical College of Cornell University NA
NCT00359905 Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH https://ClinicalTrials.gov/show/NCT00359905 Completed Recordati Industria Chimica e Farmaceutica S.p.A. 2007-05-31
NCT00347061 Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH https://ClinicalTrials.gov/show/NCT00347061 Completed Sanofi 2007-10-31
NCT00290030 ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH https://ClinicalTrials.gov/show/NCT00290030 Completed Sanofi 2004-10-31
NCT00284518 Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00284518 Completed Allergan 2009-05-31
NCT00280605 ALF-ONE : ALFuzosin ONcE Daily https://ClinicalTrials.gov/show/NCT00280605 Completed Sanofi 2006-02-28
NCT00242710 Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women https://ClinicalTrials.gov/show/NCT00242710 Completed Pfizer 2008-09-30
NCT00224133 The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months https://ClinicalTrials.gov/show/NCT00224133 Completed Watson Pharmaceuticals 2007-04-30
NCT00224120 A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo https://ClinicalTrials.gov/show/NCT00224120 Completed Watson Pharmaceuticals 2006-05-31
NCT00224107 A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo https://ClinicalTrials.gov/show/NCT00224107 Completed Watson Pharmaceuticals 2006-08-31
NCT00199550 Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) https://ClinicalTrials.gov/show/NCT00199550 Completed Lawson Health Research Institute 2008-03-31
NCT00194675 TRADE-Testosterone Replacement and Dutasteride Effectiveness https://ClinicalTrials.gov/show/NCT00194675 Completed University of Washington 2010-04-30
NCT00169585 Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) https://ClinicalTrials.gov/show/NCT00169585 Completed GlaxoSmithKline 2007-04-30
NCT00143221 Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00143221 Completed Pfizer NA
NCT00127179 A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) https://ClinicalTrials.gov/show/NCT00127179 Completed Merck Sharp & Dohme Corp. 2005-07-01
NCT00111592 Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice https://ClinicalTrials.gov/show/NCT00111592 Completed Maastricht University Medical Center NA
NCT00090103 Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment https://ClinicalTrials.gov/show/NCT00090103 Completed GlaxoSmithKline 2009-04-30
NCT00077012 Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00077012 Completed QLT Inc. 2005-05-31
NCT00067613 Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT00067613 Completed NICHD Neonatal Research Network 2004-05-31
NCT00062790 Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels https://ClinicalTrials.gov/show/NCT00062790 Completed GlaxoSmithKline NA
NCT00797394 Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto https://ClinicalTrials.gov/show/NCT00797394 Completed innoVactiv Inc. 2010-07-31
NCT00005879 LY353381 in Preventing Breast Cancer in Women With Hyperplasia https://ClinicalTrials.gov/show/NCT00005879 Completed University of Kansas Medical Center 2008-07-31
NCT00041925 Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures https://ClinicalTrials.gov/show/NCT00041925 Completed Anesiva, Inc. NA
NCT00037154 Saw Palmetto Extract in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00037154 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00037141 Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00037141 Completed American Medical Systems NA
NCT00029822 Clinical Trial in Males With BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00029822 Completed Sanofi NA
NCT00621985 Dexamethasone Treatment of Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00621985 Completed Boston Children’s Hospital 2009-06-30
NCT00368979 Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects https://ClinicalTrials.gov/show/NCT00368979 Completed GlaxoSmithKline 2007-12-01
NCT00001728 Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome https://ClinicalTrials.gov/show/NCT00001728 Completed National Institutes of Health Clinical Center (CC) 2007-08-19
NCT00000758 A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women https://ClinicalTrials.gov/show/NCT00000758 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00021814 Medical Therapy of Prostatic Symptoms https://ClinicalTrials.gov/show/NCT00021814 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2001-11-30
NCT00151710 Effects of Pioglitazone in Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00151710 Completed Radboud University NA
NCT00000102 Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets https://ClinicalTrials.gov/show/NCT00000102 Completed National Center for Research Resources (NCRR) NA
NCT00000612 Soy Estrogen Alternative Study (SEA) https://ClinicalTrials.gov/show/NCT00000612 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03382158 International PPB/DICER1 Registry https://ClinicalTrials.gov/show/NCT03382158 Recruiting Children’s Hospitals and Clinics of Minnesota 2023-12-06
NCT01398397 Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype https://ClinicalTrials.gov/show/NCT01398397 Completed Edimer Pharmaceuticals NA
NCT03321240 Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia https://ClinicalTrials.gov/show/NCT03321240 Recruiting University Hospital, Strasbourg, France 2022-12-15
NCT03229967 Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03229967 Enrolling by invitation University of Tennessee 2020-12-30
NCT03228485 Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study https://ClinicalTrials.gov/show/NCT03228485 Recruiting Société Internationale d’Urologie 2021-04-10
NCT03179670 Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH https://ClinicalTrials.gov/show/NCT03179670 Completed Laboratoires Bouchara-Recordati 2018-06-30
NCT03174847 Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism https://ClinicalTrials.gov/show/NCT03174847 Recruiting Changi General Hospital 2020-08-30
NCT03075449 Real World Data on Management of Male LUTS https://ClinicalTrials.gov/show/NCT03075449 Completed Boehringer Ingelheim 2016-12-21
NCT02873117 Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers https://ClinicalTrials.gov/show/NCT02873117 Completed Rennes University Hospital 2016-12-31
NCT02853968 Unlock the Cell: Castleman’s Disease Flow Cytometry Study https://ClinicalTrials.gov/show/NCT02853968 Completed University of Pennsylvania 2019-01-30
NCT01967511 Defining the Basis of Fibromuscular Dysplasia (FMD) https://ClinicalTrials.gov/show/NCT01967511 Recruiting Icahn School of Medicine at Mount Sinai 2021-12-31
NCT01780155 Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT01780155 Recruiting National Institutes of Health Clinical Center (CC) 2022-09-26
NCT00339651 Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer https://ClinicalTrials.gov/show/NCT00339651 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02483819 Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients https://ClinicalTrials.gov/show/NCT02483819 Completed Yonsei University 2016-02-27
NCT02431871 Sequelae of Developmental Dysplasia of the Hip https://ClinicalTrials.gov/show/NCT02431871 Active, not recruiting University of Oulu 2021-03-31
NCT02425800 Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells https://ClinicalTrials.gov/show/NCT02425800 Completed Wake Forest University Health Sciences 2018-11-05
NCT02347436 Does Benign Prostatic Obstruction Cause Hypertension? https://ClinicalTrials.gov/show/NCT02347436 Completed St. Olavs Hospital 2019-10-31
NCT02304549 A Prospective Investigation Using the Expired Breath Ethanol Test https://ClinicalTrials.gov/show/NCT02304549 Completed Cantonal Hospital of St. Gallen 2015-11-30
NCT04117685 International Hip Dysplasia Registry https://ClinicalTrials.gov/show/NCT04117685 Recruiting University of British Columbia 2028-12-31
NCT02248467 Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients https://ClinicalTrials.gov/show/NCT02248467 Completed University of Florence 2017-12-31
NCT02245555 Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02245555 Completed Boehringer Ingelheim 2007-12-31
NCT02245542 The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) https://ClinicalTrials.gov/show/NCT02245542 Completed Boehringer Ingelheim 2006-02-28
NCT02245529 Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02245529 Completed Boehringer Ingelheim 2005-09-30
NCT02245503 Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02245503 Completed Boehringer Ingelheim 2003-10-31
NCT02244346 Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02244346 Completed Boehringer Ingelheim 2004-11-30
NCT02244333 Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) https://ClinicalTrials.gov/show/NCT02244333 Completed Boehringer Ingelheim 2004-07-31
NCT02244320 Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) https://ClinicalTrials.gov/show/NCT02244320 Completed Boehringer Ingelheim 2003-05-31
NCT02244307 Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade https://ClinicalTrials.gov/show/NCT02244307 Completed Boehringer Ingelheim 2003-06-30
NCT02244268 Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244268 Completed Boehringer Ingelheim 2001-12-31
NCT02206243 Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02206243 Completed Jena University Hospital 2018-11-30
NCT02185365 Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia https://ClinicalTrials.gov/show/NCT02185365 Recruiting Ottawa Hospital Research Institute 2020-12-31
NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors https://ClinicalTrials.gov/show/NCT02156700 Completed University Hospital Dubrava 2015-12-31
NCT02100137 Women With Asymptomatic Endometrial Hyperplasia https://ClinicalTrials.gov/show/NCT02100137 Completed Medical University of Vienna 2010-11-30
NCT02099552 Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia https://ClinicalTrials.gov/show/NCT02099552 Completed Edimer Pharmaceuticals 2016-12-31
NCT02063919 Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome https://ClinicalTrials.gov/show/NCT02063919 Completed Shandong University 2014-04-30
NCT01313455 Adrenal Hyperplasia Among Young People With PCOS https://ClinicalTrials.gov/show/NCT01313455 Completed National Institutes of Health Clinical Center (CC) NA
NCT01299571 AVODART(Dutasteride) Post-marketing Surveillance(PMS) https://ClinicalTrials.gov/show/NCT01299571 Completed GlaxoSmithKline 2010-07-31
NCT01293565 Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A https://ClinicalTrials.gov/show/NCT01293565 Completed Edimer Pharmaceuticals 2011-05-31
NCT03354416 Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer https://ClinicalTrials.gov/show/NCT03354416 Recruiting National Institutes of Health Clinical Center (CC) 2027-12-31
NCT01981876 Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital https://ClinicalTrials.gov/show/NCT01981876 Completed Tenwek Hospital 2014-12-31
NCT01961102 OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer https://ClinicalTrials.gov/show/NCT01961102 Completed Krankenhaus Barmherzige Schwestern Linz 2015-09-30
NCT01958892 To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate https://ClinicalTrials.gov/show/NCT01958892 Completed Singapore General Hospital 2012-10-31
NCT01925586 Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE) https://ClinicalTrials.gov/show/NCT01925586 Completed Yale University 2018-08-31
NCT01875640 Decision Support for Parents Receiving Information About Child’s Rare Disease https://ClinicalTrials.gov/show/NCT01875640 Completed University of Michigan 2016-05-31
NCT01808729 CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium https://ClinicalTrials.gov/show/NCT01808729 Completed Icahn School of Medicine at Mount Sinai 2013-10-31
NCT01807364 Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT01807364 Completed Assistance Publique - Hôpitaux de Paris 2015-09-30
NCT01767363 WEUSKOP5723: Prostate Cancer Study https://ClinicalTrials.gov/show/NCT01767363 Completed GlaxoSmithKline 2016-03-31
NCT01632475 Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01632475 Active, not recruiting Samsung Medical Center 2025-09-30
NCT01630460 Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD) https://ClinicalTrials.gov/show/NCT01630460 Recruiting UConn Health 2025-12-31
NCT01629940 Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status https://ClinicalTrials.gov/show/NCT01629940 Completed Edimer Pharmaceuticals 2012-07-31
NCT01629927 Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012) https://ClinicalTrials.gov/show/NCT01629927 Completed Edimer Pharmaceuticals 2012-04-30
NCT01604148 Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon https://ClinicalTrials.gov/show/NCT01604148 Completed Samsung Medical Center 2011-07-31
NCT01534793 QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) https://ClinicalTrials.gov/show/NCT01534793 Completed Assistance Publique - Hôpitaux de Paris 2013-05-31
NCT01482676 The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction https://ClinicalTrials.gov/show/NCT01482676 Completed University Hospital Inselspital, Berne 2012-12-31
NCT01463462 Electronic Catheter Stethoscope https://ClinicalTrials.gov/show/NCT01463462 Completed University of South Florida 2016-04-30
NCT01439295 Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01439295 Completed St. Justine’s Hospital 2015-11-30
NCT01435954 Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy https://ClinicalTrials.gov/show/NCT01435954 Completed GlaxoSmithKline 2011-03-31
NCT01398813 X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey https://ClinicalTrials.gov/show/NCT01398813 Completed Edimer Pharmaceuticals 2013-07-31
NCT01390870 Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence https://ClinicalTrials.gov/show/NCT01390870 Completed GlaxoSmithKline 2010-09-30
NCT01386983 Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment https://ClinicalTrials.gov/show/NCT01386983 Completed GlaxoSmithKline 2010-06-30
NCT01386775 Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation https://ClinicalTrials.gov/show/NCT01386775 Completed Edimer Pharmaceuticals 2011-07-31
NCT01381510 Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database https://ClinicalTrials.gov/show/NCT01381510 Completed GlaxoSmithKline 2010-08-31
NCT01376284 Drug Use Investigation for AVOLVE(BPH) https://ClinicalTrials.gov/show/NCT01376284 Completed GlaxoSmithKline 2013-10-31
NCT01376258 Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database https://ClinicalTrials.gov/show/NCT01376258 Completed GlaxoSmithKline 2010-12-31
NCT01371513 Korean Practice Patterns for Screening PCA(Prostate Cancer) https://ClinicalTrials.gov/show/NCT01371513 Completed GlaxoSmithKline 2011-06-30
NCT01344421 Movement Pattern in Patients With Hip Dysplasia https://ClinicalTrials.gov/show/NCT01344421 Completed University of Aarhus 2013-03-31
NCT01337258 Economic Analyses of the REDUCE Trial https://ClinicalTrials.gov/show/NCT01337258 Completed GlaxoSmithKline 2010-07-31
NCT01334723 Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01334723 Completed GlaxoSmithKline 2010-04-30
NCT01332487 Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01332487 Completed GlaxoSmithKline 2010-08-31
NCT01332435 Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use https://ClinicalTrials.gov/show/NCT01332435 Completed GlaxoSmithKline 2010-01-31
NCT01323998 Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan https://ClinicalTrials.gov/show/NCT01323998 Completed GlaxoSmithKline 2010-06-30
NCT04428827 Outcome of Patients With Primary Aldosteronism https://ClinicalTrials.gov/show/NCT04428827 Recruiting Changi General Hospital 2020-09-30
NCT04383093 Tadalafil Plus Tamsulosin for Male LUTS and ED https://ClinicalTrials.gov/show/NCT04383093 Completed University of Florence 2018-01-01
NCT04378387 Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism https://ClinicalTrials.gov/show/NCT04378387 Completed University of Turin, Italy 2020-04-30
NCT04153266 Oral Epithelial Dysplasia Informational Needs Questionnaire https://ClinicalTrials.gov/show/NCT04153266 Completed University College, London 2019-12-21
NCT04071561 Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions https://ClinicalTrials.gov/show/NCT04071561 Completed University of Basel 2019-05-31
NCT03972917 Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy https://ClinicalTrials.gov/show/NCT03972917 Recruiting University of Campania “Luigi Vanvitelli” 2021-11-30
NCT03965585 Office Hysteroscopy in Infertility Work-out: the Role of Endometrial Hyperplasia in Southern Italian Women https://ClinicalTrials.gov/show/NCT03965585 Completed University of Campania “Luigi Vanvitelli” 2019-04-21
NCT03959917 TURP; Complications and Outpatient Care https://ClinicalTrials.gov/show/NCT03959917 Recruiting Umeå University 2020-02-15
NCT03955484 Benign Prostatic Hyperplasia and Glycosaminoglycan https://ClinicalTrials.gov/show/NCT03955484 Recruiting Marmara University 2019-09-01
NCT03917147 Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination https://ClinicalTrials.gov/show/NCT03917147 Completed University of Campania “Luigi Vanvitelli” 2018-10-18
NCT03912766 Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy https://ClinicalTrials.gov/show/NCT03912766 Completed Medical Universtity of Lodz 2017-01-02
NCT03768765 Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03768765 Recruiting University of Kansas Medical Center 2020-12-31
NCT03685799 Impact of Histologic Concordance Between Biopsies and the Endoscopic Resection Specimen, in the Treatment of Barrett’s Esophagus in Dysplasia, on the Recurrence of Dysplasia https://ClinicalTrials.gov/show/NCT03685799 Completed Institut Paoli-Calmettes 2016-06-30
NCT03550261 Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03550261 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-10
NCT03460873 Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate https://ClinicalTrials.gov/show/NCT03460873 Completed Samsung Medical Center 2019-11-07
NCT01250483 Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT01250483 Completed Seoul National University Hospital 2009-12-31
NCT01184651 Tweens to Teens Project at Penn State https://ClinicalTrials.gov/show/NCT01184651 Completed Penn State University 2013-07-31
NCT01135888 Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia https://ClinicalTrials.gov/show/NCT01135888 Completed University Hospital Erlangen 2010-02-28
NCT01108770 Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia https://ClinicalTrials.gov/show/NCT01108770 Completed Edimer Pharmaceuticals 2010-07-31
NCT01108367 Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) https://ClinicalTrials.gov/show/NCT01108367 Completed Seoul National University Hospital 2010-03-31
NCT01052740 X-Ray Mammography Standard of Care Protocol https://ClinicalTrials.gov/show/NCT01052740 Completed National Institutes of Health Clinical Center (CC) NA
NCT01003886 A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01003886 Completed Pfizer 2011-01-31
NCT00892866 CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells https://ClinicalTrials.gov/show/NCT00892866 Recruiting Gynecologic Oncology Group 2025-05-31
NCT00885027 MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment https://ClinicalTrials.gov/show/NCT00885027 Completed Boehringer Ingelheim 2009-04-30
NCT00883662 Mirena Observational Program https://ClinicalTrials.gov/show/NCT00883662 Completed Bayer 2014-04-30
NCT03162172 Growth Hormone (GH) in Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT03162172 Completed Hospices Civils de Lyon 2016-03-15
NCT00822952 Prostate Mechanical Imager (PMI) Clinical Bridging Study https://ClinicalTrials.gov/show/NCT00822952 Completed Artann Laboratories 2009-09-30
NCT03094273 Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi https://ClinicalTrials.gov/show/NCT03094273 Completed NYU Langone Health 2016-01-31
NCT01488721 Clinical Evaluation of NeoPlex4 Assay and NeoPlex System https://ClinicalTrials.gov/show/NCT01488721 Completed Luminex Molecular Diagnostics 2012-02-29
NCT01563874 Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins https://ClinicalTrials.gov/show/NCT01563874 Completed National Institutes of Health Clinical Center (CC) NA
NCT01695018 Early Diagnosis of Oral Cancer by Detecting p16 Methylation https://ClinicalTrials.gov/show/NCT01695018 Completed Peking University 2014-03-31
NCT00749593 Study of UK Adults With Congenital Adrenal Hyperplasia. https://ClinicalTrials.gov/show/NCT00749593 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2007-06-30
NCT00662350 Temperature Mapping of the Prostate With the Walltermâ„¢ System https://ClinicalTrials.gov/show/NCT00662350 Completed Pnn Medical A/S 2009-07-31
NCT00593593 Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00593593 Completed GlaxoSmithKline NA
NCT00559078 Qualitative Research on Women With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00559078 Completed Lehigh University NA
NCT00472251 One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients https://ClinicalTrials.gov/show/NCT00472251 Completed Seoul National University Hospital 2008-09-30
NCT00454766 Evaluating Materials to Educate Patients About Cervical Dysplasia https://ClinicalTrials.gov/show/NCT00454766 Active, not recruiting M.D. Anderson Cancer Center 2024-02-29
NCT00407329 Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00407329 Completed Queen’s University 2008-02-29
NCT00316732 Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS https://ClinicalTrials.gov/show/NCT00316732 Completed GlaxoSmithKline 2006-12-19
NCT00303368 Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia https://ClinicalTrials.gov/show/NCT00303368 Completed Shriners Hospitals for Children 2014-01-31
NCT00250159 Natural History Study of Patients With Excess Androgen https://ClinicalTrials.gov/show/NCT00250159 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT00187616 Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT00187616 Completed University of California, San Francisco NA
NCT00159406 Laser Prostatectomy Database and Registry https://ClinicalTrials.gov/show/NCT00159406 Active, not recruiting Indiana Kidney Stone Institute 2020-12-31
NCT00835341 Methylation of p16 CpG Island And Malignant Transformation of Oral Epithelial Dysplasia https://ClinicalTrials.gov/show/NCT00835341 Completed Peking University 2008-10-31
NCT00011791 Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia https://ClinicalTrials.gov/show/NCT00011791 Completed National Institutes of Health Clinical Center (CC) NA
NCT00006058 Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns https://ClinicalTrials.gov/show/NCT00006058 Completed National Center for Research Resources (NCRR) NA
NCT00001973 Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome https://ClinicalTrials.gov/show/NCT00001973 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03231644 Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry https://ClinicalTrials.gov/show/NCT03231644 Recruiting Fibrous Dysplasia Foundation 2026-10-31
NCT02817997 International Registry for Patients With Castleman Disease https://ClinicalTrials.gov/show/NCT02817997 Recruiting University of Pennsylvania 2021-09-30
NCT02029560 Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System https://ClinicalTrials.gov/show/NCT02029560 Completed JW Pharmaceutical 2014-11-30
NCT01886547 2013 Annual National Digital Rectal Exam (DRE) Day Study https://ClinicalTrials.gov/show/NCT01886547 Completed St. Luke’s Medical Center, Philippines 2014-10-31
NCT01826617 Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome https://ClinicalTrials.gov/show/NCT01826617 Completed St. Luke’s Medical Center, Philippines 2014-11-30
NCT01816438 A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia https://ClinicalTrials.gov/show/NCT01816438 Active, not recruiting Hôpital Edouard Herriot 2020-07-31
NCT04352257 Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04352257 Recruiting Kafrelsheikh University 2021-04-01
NCT03736512 China Greenlight Registry Study (Post-market) https://ClinicalTrials.gov/show/NCT03736512 Recruiting Boston Scientific Corporation 2020-06-30
NCT03583034 Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands https://ClinicalTrials.gov/show/NCT03583034 Recruiting IRCCS San Raffaele 2019-04-18
NCT03521648 Database for the Assessment of Efficacy and Safety of BPH Treatment https://ClinicalTrials.gov/show/NCT03521648 Recruiting Cantonal Hospital of St. Gallen 2027-12-01